As per our report, the global anatomic pathology market size is predicted to grow USD 27.77 billion by 2026 from USD 20.60 billion in 2021. The market is forecasted to grow at a CAGR of 6.16% during the forecast period. The use of anatomic pathology with biomarkers in diagnosing cancer is hugely impacting positively on the market's growth rate.
Anatomic pathology is a diagnostic procedure that examines organs and tissues through macroscopic, microscopic, biochemical, immunologic, and molecular examination. This procedure can help the healthcare professional to evaluate quality-based treatment for the patient as it diagnosis accurately.
Anatomic Pathology is a branch of pathology that can be defined as a specialization of medicine. The disease's diagnosis is carried out by examining tissues and organs at a microscopic, biochemical, immunological, and macroscopic level. The critical function of anatomy pathology is to detect abnormalities that can help enhance diagnostics and treatment management. Anatomy pathology is most frequently applied to identify different types of tumors and cancers, liver and kidney diseases, infections, and autoimmune disorders. The lines are blurring between the clinical pathology and anatomical pathology owing to the technological advancements leading to the overlapping of both the branches; the procedures like flow cytometry, molecular pathology, cytogenetics can be performed on both fluid samples and tissue samples.
In clinical centers, anatomic pathology is a technology used to diagnose the diseases with microscopic, macroscopic, and other instruments. Modern technologies play a pivotal role in processing, examining, and analyzing cancer diseases and making the right decisions over treatment procedures.
COVID-19 outbreak has made drastic changes in every sector, even in the anatomic pathology market. Amid COVID-19, there is a decrease in hospitals' patient count from the past few months despite emergency and outpatient services. The cancer surgeries are reduced due to the lockdown restrictions. Also, it is estimated that the market will grow enormously once the crisis is into normal. According to the world economic forum, 33% of cancer surgeries are postponed in 2020, and around 28 million elective surgeries are planned next year. Hence, the number of diagnostic procedures also reduced in 2020 due to the COVID-19 pandemic.
MARKET DRIVERS
Rising the aging population worldwide and increasing incidences of chronic diseases due to changes in food habits and lifestyle are primarily accelerating the global anatomic pathology market.
Growing demand to improve the diagnostic procedures in every clinical center is further propelling the market. Additionally, increasing concern towards health and also a priority for early diagnosis and rise in disposable income in urban areas are lavishing the demand of the market to the extent. The adoption of the latest technologies and the launch of innovative techniques in the medical sector boost the anatomic pathology market.
Further, the growing prevalence of effective treatment procedures and promoting the patient's well-being after surgeries is creating chances for the anatomic pathology market to grow. Increasing investments in hospitals' construction by the government is likely to bolster the demand of the anatomic pathology market.
In 2018, around 9.6 million deaths occurred due to cancer globally, according to the world health organization. The reports also state that cancer risk can be reduced by using proper equipment in the healthcare sector. Market players are planning to launch innovative products to gain profits, which is likely to elaborate on its growth rate.
MARKET RESTRAINTS
Lack of standardization is slowly hampering the demand of the market. Stringent rules and regulations by the government also negatively impact the growth of the anatomic pathology market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Product Type, End-User, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
In this research report, the global anatomic pathology market has been segmented based on the product type, end-user, application, and region.
Anatomic Pathology Market - By Product:
Based on product type, Instruments type is leading with the highest shares of the market. Changes in lifestyles and food habits, rise in the incidences of various health disorders, growing expenditure on healthcare are majorly elevating the growth of the anatomic pathology market. In the medical sector, there is a growing need to improve the diagnostic procedures and analyze the issue with a clear vision to promote effective treatment for the patient, significantly influencing the demand of the market.
Anatomic Pathology Market - By End-User:
Based on the end-user, the diagnostics lab segment is contributing the highest shares for the market. Increasing support from both private and public organizations in healthcare centers is accelerating the demand of the market. Growing awareness over the availability of various diagnostic procedures for many health disorders is likely to outshine the need of the market. The rise in the number of research institutes in the medical sector is lavishing the growth of the anatomic pathology market.
Anatomic Pathology Market - By Application:
Lymphoma application is witnessed in holding prominent shares of the market to adopt the latest technology in diagnosing and treating the disease. Increasing disposable income, especially in urban areas, is also one of the factors fueling the growth of the market. The growing tendency to launch innovative devices in favor of the end-users is ascribed to bolster the demand of the market. The rise in the revenue in developed and developing countries is also to magnify the significant growth rate of the anatomic pathology market.
Anatomic Pathology Market - By Region:
Geographically, North American market is accounted for holding the highest shares of the market. The rise in the awareness over the diagnosis procedures is driving the growth of the anatomic pathology industry. Besides, the growing number of research institutes to improve the performance boosts the demand of the market.
The Asia Pacific is following North America in holding the most significant shares of the market. The growing geriatric population is one of the factors outshining the demand of the business. Also, increasing hospitals' construction with the latest equipment is broadening the growth of the anatomic pathology market.
Europe witnessed the fastest growth rate from the past few years, and it is deemed to have a significant growth rate in the coming years. Acceptance of the latest technologies and the implementation of new devices at a high success rate is escalating the European market demand.
The Middle East and Africa are expected to have slight variations in the growth rate shortly.
TOP COMPANIES IN THE MARKET:
Noteworthy companies in the global anatomic pathology market profiled in this report are F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, and BISWorld's Pathology Services.
RECENT HAPPENINGS IN THE MARKET:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End-User
5.2.1 Introduction
5.2.2 Diagnostics Lab
5.2.3 Hospitals
5.2.4 Physicians' Office Lab
5.2.5 Y-o-Y Growth Analysis, By End-User
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By End-User
5.3 Application
5.3.1 Introduction
5.3.2 Lymphoma
5.3.3 Breast
5.3.4 Lung
5.3.5 Cervical
5.3.6 Colorectal
5.3.7 Prostate
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End-User
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End-User
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End-User
6.1.5.4 By Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 NeoGenomics Laboratories Inc.
8.3 Laboratory Corporation of America Holdings
8.4 Thermo Fisher Scientific
8.5 Quest Diagnostics Incorporated
8.6 Agilent Technologies
8.7 Danaher Corporation
8.8 Sakura Finetechnical Co. Ltd.
8.9 Metropolis
8.10 IBISWorld’s Pathology Services
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
